<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".02" citation="COMAR 10.09.21.02" title_num="10" subtitle_num="09" chapter_num="21" heading="Definitions.">
  <paragraph num="A.">
    <text>In this chapter, the following terms have the meanings indicated.</text>
  </paragraph>
  <paragraph num="B.">
    <text>Terms Defined.</text>
    <paragraph num="(1)">
      <text>“Board” means the Maryland Board of Pharmacy.</text>
    </paragraph>
    <paragraph num="(2)">
      <text>“Maryland Medical Assistance Program” means the program of comprehensive medical and other health-related care for indigent and medically indigent individuals.</text>
    </paragraph>
    <paragraph num="(3)">
      <text>“Medication therapy management” services are defined as face-to-face consultations that are structured to reduce the risk of adverse events and ensure optimum therapeutic outcomes for targeted patients through improved medication use with disease-state specific education, counseling, and medication review related to treatments, including drug therapy, laboratory tests, or medical devices provided by licensed and practicing pharmacists.</text>
    </paragraph>
    <paragraph num="(4)">
      <text>“Participant” means an individual who is certified as eligible for, and is receiving, Medical Assistance benefits.</text>
    </paragraph>
    <paragraph num="(5)">
      <text>“Pharmacist” means an individual licensed in good standing to practice pharmacy in the state where the service is provided.</text>
    </paragraph>
    <paragraph num="(6)">
      <text>“Program” means the Maryland Medical Assistance Program.</text>
    </paragraph>
  </paragraph>
</regulation>